PNC Financial Services Group
ESPR

PNC Financial Services Group’s Esperion Therapeutics ESPR Stock Holding History

PNC Financial Services Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,297
Closed -$1.87K – 4962
2025
Q1 		$1.87K Buy
+1,297
New +$2.39K ﹤0.01% 4369
2022
Q2 		– Sell
-35
Closed – – 4555
2022
Q1 		$0 Hold
35
– – ﹤0.01% 4567
2021
Q4 		$0 Hold
35
– – ﹤0.01% 4483
2021
Q3 		$0 Sell
35
-6
-15% -$87 ﹤0.01% 4322
2021
Q2 		$1K Sell
41
-6,865
-99% -$165K ﹤0.01% 4105
2021
Q1 		$194K Buy
6,906
+6,400
+1,265% +$189K ﹤0.01% 2179
2020
Q4 		$13K Hold
506
– – ﹤0.01% 3490
2020
Q3 		$19K Hold
506
– – ﹤0.01% 3255
2020
Q2 		$26K Sell
506
-1,470
-74% -$61.5K ﹤0.01% 3089
2020
Q1 		$62K Buy
1,976
+1,970
+32,833% +$104K ﹤0.01% 2496
2019
Q4 		$0 Hold
6
– – ﹤0.01% 4017
2019
Q3 		$0 Hold
6
– – ﹤0.01% 4020
2019
Q2 		$0 Hold
6
– – ﹤0.01% 4044
2019
Q1 		$0 Hold
6
– – ﹤0.01% 4051
2018
Q4 		$0 Hold
6
– – ﹤0.01% 4073
2018
Q3 		$0 Hold
6
– – ﹤0.01% 4145
2018
Q2 		$0 Buy
+6
New +$303 ﹤0.01% 4169
2016
Q3 		– Sell
-71
Closed -$1K – 4067
2016
Q2 		$1K Sell
71
-3
-4% -$50 ﹤0.01% 4341
2016
Q1 		$1K Buy
74
+3
+4% +$48 ﹤0.01% 4352
2015
Q4 		$2K Hold
71
– – ﹤0.01% 4151
2015
Q3 		$2K Buy
71
+2
+3% +$126 ﹤0.01% 4273
2015
Q2 		$6K Buy
+69
New +$6.75K ﹤0.01% 3999
2015
Q1 		– Sell
-140
Closed -$6K – 4708
2014
Q4 		$6K Hold
140
– – ﹤0.01% 3494
2014
Q3 		$3K Hold
140
– – ﹤0.01% 3576
2014
Q2 		$2K Buy
+140
New +$2.02K ﹤0.01% 3508

Other funds holding ESPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $780M AUM 24.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

PNC Financial Services Group's ESPR Position: Q2 2025 in Review

PNC Financial Services Group sold out of Esperion Therapeutics (ESPR) in Q2 2025, closing a stake of 1,297 shares — an estimated $1.87K sold.

PNC Financial Services Group first reported a position in ESPR in Q2 2014 and held it in 25 quarters. The position peaked at $194K in Q1 2021. 163 funds tracked by Wall St. Rank hold ESPR as of Q2 2025.

  • PNC Financial Services Group reported no remaining Esperion Therapeutics position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 1,297 Esperion Therapeutics shares in Q2 2025, an estimated $1.87K.
  • PNC Financial Services Group first reported a position in Esperion Therapeutics in Q2 2014 and held it in 25 quarters.
  • PNC Financial Services Group's Esperion Therapeutics position peaked at $194K in Q1 2021.
  • 163 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.